A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

The growth of the global Preclinical CRO market is driven by several key factors. Increasing complexity and costs associated ...

Huadong Medicine Co. Ltd. recently revealed data from in vitro and preclinical studies performed to evaluate the efficacy and pharmacokinetic, safety and tolerability profiles of a dual glucagon-like ...

HOOKIPA is very pleased to present a comprehensive preclinical proof-of-concept dataset related to HB-700, for the potential treatment of KRAS mutated cancers. KRAS mutations are most frequently found ...

A new study found a new drug-free nasal spray may protect against respiratory infections like COVID and the flu, according to ...

Researchers from the Brigham detail how the spray they created may offer broad-spectrum protection from respiratory infections by COVID-19, influenza, everyday cold viruses, and pneumonia-causing bact ...

Presentations to highlight progress in development of IND candidates ZW220 and ZW251 based on Zymeworks’ proprietary antibody ...

PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS ...

In the newly published study, voriconazole dry powder formulations for inhalation were prepared by three different methods: jet-milling, spray-drying, and Thin Film Freezing. The TFF processed ...

Phare Bio, along with the Collins Lab at the Massachusetts Institute of Technology (MIT) and Harvard's Wyss Institute, today ...

研究成果以“通过综合临床与临床前研究鉴定FerroTerminator1分子为治疗代谢功能障碍相关脂肪性肝炎的潜在药物（Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH）”为题，2024年8月13日在线发表于《细胞代谢》（Cell ...